The Latest Breaking News from Obesity

The two biopharma firms have developed drug candidates to treat autoimmune and pulmonary diseases. They have demonstrated good safety profiles and efficacy in various stages of clinical trials.

Researchers discovered that being obese for 10 or more years significantly increases the risk for individuals under the age of 50.

Obesity levels for adults have hit 26% in Britain and 42.5% in the United States, journalist Johann Hari writes in his new book, Magic Pill. In Australia, recent data shows we’re somewhere in the middle: 31%.

Increase sharper than in any age group and is likely to be linked to soaring obesity levels, junk food and inactivity, say experts

Living with obesity for 10 years is associated with an up to 60% increase in the risk of these conditions, scientists said.

Intermittent fasting, where people eat what they want, but only during certain daily windows of time, has skyrocketed in popularity in recent years

Research has shown that screen time inhibits young children's ability to read faces and learn social skills... let's look a little deeper

The iconic documentary turned 20 this month — the same month Oprah and "South Park" released weight loss specials

Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has been shown in the SELECT Trial to be effective in preventing the loss of kidney function in people who are overweight or obese and have established cardiovascular disease but do not have diabetes. Read further on Dynamite News:

South Park: The End Of Obesity about Ozempic has finally landed on Paramount+ and it's bonkers. Here are the top 9 mind-blowing moments.

In the "End of Obesity" special, South Park residents want the latest semaglutides, but there's a cheaper option